Minerva Surgical Inc. set terms for its initial public offering on Friday, with plans to offer 6.25 million shares, priced at $15 to $17 each. The company would raise $106.25 million at the top of that range, at a valuation of $486 million. The company has applied to list on Nasdaq, under the ticker ‘UTRS.’ JPMorgan, Piper Sandler, UBS and SVB Leerink are underwriting the deal. “We are a commercial-stage medical technology company focused on developing, manufacturing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women,” the company says in its IPO prospectus. The Renaissance IPO ETF has gained 3% in the year to date, while the S&P 500 has gained 18%.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
